- 首頁
- App 分析
- AnticoagEvaluator
- AnticoagEvaluator Vs. Anticoagulation Manager
AnticoagEvaluator 與 Anticoagulation Manager 使用情況與統計
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
- Apple App Store
- 免費版
- 醫療
商店排名
- -
The Anticoagulation Manager is a mobile application developed through the collaborative efforts of the CDC and the Georgia Institute of Technology. Since the determination of the correct type and dose of anticoagulant drugs can be challenging, this application is a resource for clinicians to appropriately order laboratory testing and choose anticoagulant drugs for the various indications. It gives clinicians evidence-based, accessible, and accurate information when prescribing anticoagulants to prevent and/or treat abnormal clotting states.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
AnticoagEvaluator與 Anticoagulation Manager 比較排名
比較過去 28 天的 AnticoagEvaluator 排名趨勢與 Anticoagulation Manager
排名
無可用數據
各國 AnticoagEvaluator vs. Anticoagulation Manager 排名比較
比較過去 28 天的 AnticoagEvaluator 排名趨勢與 Anticoagulation Manager
無可顯示數據
使用我們的免費試用版,與所有網站進行比較
AnticoagEvaluator VS.
Anticoagulation Manager
12月 19, 2024